Artificial Intelligence In Diabetology

This review presents the applications of artificial intelligence for the study of the mechanisms of diabetes development and generation of new technologies of its prevention, monitoring and treatment. In recent years, a huge amount of molecular data has been accumulated, revealing the pathogenic mechanisms of diabetes and its complications. Data mining and text mining open up new possibilities for processing this information. Analysis of gene networks makes it possible to identify molecular interactions that are important for the development of diabetes and its complications, as well as to identify new targeted molecules. Based on the big data analysis and machine learning, new platforms have been created for prediction and screening of diabetes, diabetic retinopathy, chronic kidney disease, and cardiovascular disease. Machine learning algorithms are applied for personalized prediction of glucose trends, in the closed-loop insulin delivery systems and decision support systems for lifestyle modification and diabetes treatment. The use of artificial intelligence for the analysis of large databases, registers, and real-world evidence studies seems to be promising. The introduction of artificial intelligence systems is in line with global trends in modern medicine, including the transition to digital and distant technologies, personification of treatment, high-precision forecasting and patient-centered care. There is an urgent need for further research in this field, with an assessment of the clinical effectiveness and economic feasibility.